Announcements
- Life Science Cares Launches in Switzerland
- Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
- Molecular Partners Publishes Invitation to Annual General Meeting 2024
- Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
- Molecular Partners Announces Dismissal of Class Action Lawsuit
- Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
- Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.86 |
---|---|
High | 12.96 |
Low | 12.86 |
Bid | 12.70 |
Offer | 13.40 |
Previous close | 12.90 |
Average volume | -- |
---|---|
Shares outstanding | 36.37m |
Free float | 33.00m |
P/E (TTM) | -- |
Market cap | 118.56m CHF |
EPS (TTM) | -1.89 CHF |
Data delayed at least 15 minutes, as of Jun 28 2019.
More ▼